ID Source | ID |
---|---|
PubMed CID | 10463634 |
CHEMBL ID | 2103948 |
MeSH ID | M0143793 |
Synonym |
---|
(23(s))-4-deacetyl-3-((1-carboxy-2-indol-3-ylethyl)carbamoyl)-3-de(methoxycarbonyl)vincaleukoblastine, ethyl ester |
vincaleukoblastine, o(sup 4)-deacetyl-3-de(methoxycarbonyl)-3-(((2-ethoxy-1-(1h-indol-3-ylmethyl)-2-oxoethyl)amino)carbonyl)-, (23(s))- |
vintriptolum [latin] |
vintriptol [inn] |
v-l-trp-oet |
4-deacetyl-3-(((s)-1-(ethoxycarbonyl)-2-(3-indolyl)ethyl)aminocarbonyl)-3-de(methoxycarbonyl)vincaleukoblastin |
vintriptol |
vintriptolum |
unii-4gz191298d |
vinblastine tryptophan ester |
4gz191298d , |
CHEMBL2103948 |
Q27259575 |
methyl (13s,15r,17s)-13-[(1r,9r,10s,11r,12r,19r)-10-[[(2s)-1-ethoxy-3-(1h-indol-3-yl)-1-oxopropan-2-yl]carbamoyl]-12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-17-hydroxy- |
Excerpt | Reference | Relevance |
---|---|---|
" The applicability of the assay was demonstrated in a pharmacokinetic study with eight cancer patients who received 45 or 50 mg/m2 vintriptol in a phase I study." | ( High-performance liquid chromatographic bio-analysis and preliminary pharmacokinetics of the experimental antitumour drug vintriptol. Beijnen, JH; Nooyen, WJ; Rao, KS; ten Bokkel Huinink, WW; van der Woude, HR; van Tellingen, O, 1990) | 0.28 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (16.67%) | 5.53% |
Reviews | 1 (16.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (66.67%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |